Raymond James & Associates’s Corbus Pharmaceuticals CRBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-589
| Closed | -$35K | – | 3921 |
|
|
2021
Q1 | $35K | Hold |
589
| – | – | ﹤0.01% | 3782 |
|
|
2020
Q4 | $22K | Sell |
589
-798
| -58% | -$29.8K | ﹤0.01% | 3587 |
|
|
2020
Q3 | $75K | Sell |
1,387
-516
| -27% | -$27.9K | ﹤0.01% | 3364 |
|
|
2020
Q2 | $479K | Buy |
1,903
+583
| +44% | +$147K | ﹤0.01% | 2600 |
|
|
2020
Q1 | $207K | Sell |
1,320
-733
| -36% | -$115K | ﹤0.01% | 3008 |
|
|
2019
Q4 | $336K | Sell |
2,053
-107
| -5% | -$17.5K | ﹤0.01% | 3001 |
|
|
2019
Q3 | $316K | Sell |
2,160
-601
| -22% | -$87.9K | ﹤0.01% | 2955 |
|
|
2019
Q2 | $574K | Buy |
2,761
+542
| +24% | +$113K | ﹤0.01% | 2551 |
|
|
2019
Q1 | $463K | Sell |
2,219
-331
| -13% | -$69.1K | ﹤0.01% | 2701 |
|
|
2018
Q4 | $447K | Buy |
2,550
+1,165
| +84% | +$204K | ﹤0.01% | 2612 |
|
|
2018
Q3 | $314K | Buy |
1,385
+765
| +123% | +$173K | ﹤0.01% | 2978 |
|
|
2018
Q2 | $94K | Buy |
620
+90
| +17% | +$13.6K | ﹤0.01% | 3372 |
|
|
2018
Q1 | $97K | Buy |
+530
| New | +$97K | ﹤0.01% | 3238 |
|
|
2017
Q2 | – | Sell |
-4,194
| Closed | -$1.04M | – | 3194 |
|
|
2017
Q1 | $1.04M | Sell |
4,194
-462
| -10% | -$114K | ﹤0.01% | 1957 |
|
|
2016
Q4 | $1.18M | Buy |
+4,656
| New | +$1.18M | ﹤0.01% | 1832 |
|
|
2016
Q2 | – | Sell |
-2,815
| Closed | -$153K | – | 2910 |
|
|
2016
Q1 | $153K | Buy |
+2,815
| New | +$153K | ﹤0.01% | 2627 |
|